NICK MAISHMAN

Nick was a member of the start-up site leadership team at Pfizer, Grange Castle, which was a significant investment in vaccine and antibody manufacturing in Ireland. He also led the construction and start-up of the Alexion site in Dublin that manufactures products for ultra-rare diseases. 

Nick was VP of manufacturing for the pure play vaccine company Valneva, where he also led the construction of a new facility for their Covid-19 vaccine. He has also had Interim Senior Management roles, serving as Site Head/General Manager for CDMO businesses in Europe and UK.

Prior to joining ViroCell Biologics, Nick was Interim Chief Scientific and Operations Officer for Alliance Pharmaceuticals, a consumer health business with international operations.

Nick has a BSc from Imperial College, London, and an MBA from University of Warwick Business School.